Company Filing History:
2 out of 5 
2 out of 3 
2 out of 832,812 Years Active: 2015-2024
Title: Innovations by Inventor Shadfar Bahri
Introduction
Shadfar Bahri is an accomplished inventor based in Irvine, CA. He has made significant contributions to the field of medical technology, particularly in the area of wound healing and ischemic tissue treatment. With a total of 4 patents to his name, Bahri's work focuses on innovative systems and methods that enhance patient care.
Latest Patents
One of Bahri's latest patents is titled "Systems and methods for angiogenic treatment in wound healing." This invention relates to the diagnosis, amelioration, and treatment of ischemic tissues in patients suffering from diminished microvascular blood flow. The invention categorizes patients into specific subsets that have the potential to respond to therapy. It includes various therapies that stimulate angiogenesis, vasculogenesis, arteriogenesis, and neovascularization to increase tissue perfusion. Another notable patent is "Therapeutic angiogenesis for treatment of the spine and other tissues." This patent outlines methods for diagnosing and treating ischemic spinal conditions, degenerative disc disease, and back pain. It also categorizes patients with ischemic spine disease into subsets that may respond to therapy, focusing on therapies that stimulate neovascularization to enhance perfusion in spinal and other anatomies.
Career Highlights
Throughout his career, Shadfar Bahri has worked with various organizations, including Cardiovascular Biotherapeutics, Inc. His innovative approaches have positioned him as a key figure in the development of therapeutic solutions for ischemic conditions.
Collaborations
Bahri has collaborated with notable professionals in his field, including Thomas J Stegmann and Kenneth A Thomas. These collaborations have further enriched his research and development efforts.
Conclusion
Shadfar Bahri's contributions to medical technology through his patents and collaborations highlight his commitment to improving patient outcomes in ischemic conditions. His innovative work continues to pave the way for advancements in therapeutic treatments.